Galectin Therapeutics (GALT) Cash & Equivalents (2010 - 2026)
Galectin Therapeutics' Cash & Equivalents was $13.3 million in Q2 2026, down 3.4% from $13.77 million a year earlier and down 5.7% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Galectin Therapeutics came in at $17.72 million, up 17.2% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of -8.2% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $15.12 million in FY2024 (-41.1%), $25.66 million in FY2023 (+38.0%), $18.59 million in FY2022 (-53.1%) and $39.65 million in FY2021 (+46.1%).
- Quarterly Cash & Equivalents has moved between $7.43 million (Q1 2025) and $39.65 million (Q4 2021) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in three of the last eight quarters, with an average decline of 9.6%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 89.9%); the worst was Q1 2025 (a decline of 68.5%).
- Per Business Quant data, GALT's Cash & Equivalents in the three quarters before Q2 2026 was $14.11 million (Q1 2026), $17.72 million (Q4 2025) and $11.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Galectin Therapeutics | 258.62 Mn | 258.62 Mn | - | 13.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.30 Mn |
| Mar 31, 2026 | 14.11 Mn |
| Dec 31, 2025 | 17.72 Mn |
| Sep 30, 2025 | 11.53 Mn |
| Jun 30, 2025 | 13.77 Mn |
| Mar 31, 2025 | 7.43 Mn |
| Dec 31, 2024 | 15.12 Mn |
| Sep 30, 2024 | 27.06 Mn |
| Jun 30, 2024 | 25.60 Mn |
| Mar 31, 2024 | 23.56 Mn |
| Dec 31, 2023 | 25.66 Mn |
| Sep 30, 2023 | 20.36 Mn |
| Jun 30, 2023 | 17.97 Mn |
| Mar 31, 2023 | 17.80 Mn |
| Dec 31, 2022 | 18.59 Mn |
| Sep 30, 2022 | 15.83 Mn |
| Jun 30, 2022 | 24.18 Mn |
| Mar 31, 2022 | 31.61 Mn |
| Dec 31, 2021 | 39.65 Mn |
| Sep 30, 2021 | 36.60 Mn |
API Access
Galectin Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();